AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
High-rolling investors have positioned themselves bullish on Amgen (NASDAQ:AMGN) through significant options trades, signaling potential price movements from $290.0 to $400.0. The activity is notable, with 75% of major traders being bullish and only one put trade. Amgen is a biotechnology leader with a portfolio of drugs for various diseases, including cancer, inflammatory diseases, and rare diseases.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet